Mycobacterium tuberculosis ketol-acid reductoisomerases have been widely studied due to their metabolic importance towards development of drug-resistant bacteria treatment. We here report the biochemical characterization of a new KARI (MtKARI-II) from a Mycobacterium tuberculosis variant with a similar kinetic profile to class I KARIs. Phylogenetic analysis suggested that MtKARI-II is clustered into a class II KARI superfamily.
CITATION STYLE
Valera, A., Wang, S., Carr, R., Trembleau, L., & Deng, H. (2022). Characterization of a class II ketol-acid reductoisomerase from Mycobacterium tuberculosis. RSC Advances, 12(17), 10540–10544. https://doi.org/10.1039/d1ra08876a
Mendeley helps you to discover research relevant for your work.